Literatur
-
1
Courtney C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E, Edwards S, Hardyman W, Raftery J, Crome P, Lendon C, Shaw H, Bentham P. AD2000 Collaborative Group .
Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.
Lancet.
2004;
363
2105-2115
-
2
Birks JS, Harvey R.
Donepezil for dementia due to Alzheimer's disease (Cochrane Review).
In: The Cochrane Library.
I Chichester, UK: John Wiley & Sons, Ltd..
2004;
2
-
3
Trinh NH, Hoblyn J, Mohanty S, Yaffe K.
Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis.
JAMA.
2003;
289
210-216
-
4
Lanctot KL, Herrmann N, Yau KK, Khan LR, Liu BA, LouLou MM, Einarson TR.
Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.
CMAJ.
2003;
169
557-564
-
5
Schneider LS.
Commentary on AD2000: donepezil in Alzheimer's disease.
Lancet.
2004;
363
2100-2101
Korrespondenzadresse:
Prof. Dr. med. Jürgen Fritze
Asternweg 65
50259 Pulheim
